The economic architecture of American healthcare, a delicate balancing act that has persisted for nearly three decades, is showing signs of structural collapse. According to James Lee, CFO of MultiCare—a prominent health system operating 13 hospitals and over 300 care sites across the Pacific Northwest—the long-standing cross-subsidization model that sustains hospital operations is no longer sustainable.
Speaking at the Healthcare Financial Management Association’s (HFMA) annual conference in National Harbor, Maryland, Lee issued a stark warning: the U.S. healthcare system is rapidly drifting toward a bifurcated reality. In this predicted future, care quality and access will be dictated by a patient’s insurance status, effectively creating a two-tier system that separates those with lucrative commercial coverage from those reliant on government-sponsored programs.
The Core Conflict: A System Built on Underpayment
At the heart of Lee’s concern is a fundamental math problem that has festered since the passage of the Balanced Budget Act of 1997. For nearly 30 years, federal reimbursement rates for Medicare and Medicaid have consistently failed to keep pace with the actual cost of providing care.
“If you go back to 1997… Medicare started to pay healthcare organizations less than cost,” Lee noted during his address. “Fast forward to now, and we are getting paid approximately 80% of our cost for Medicare. For Medicaid, depending on the state, we’re getting paid somewhere between 50% and 70% of our cost. Fundamentally, our government doesn’t believe healthcare organizations should be paid fairly.”
Lee’s frustration highlights a unique anomaly in the American economy. In almost any other sector—defense contracting, infrastructure construction, or IT services—a vendor is paid the market rate or a negotiated cost-plus fee. In healthcare, however, hospitals are mandated to provide care, often regardless of the patient’s ability to pay, while being reimbursed at rates that often result in a net loss per encounter.
A Chronology of Fiscal Erosion
To understand the current crisis, one must view it as a decades-long erosion of financial stability:
- 1997: The Turning Point. The Balanced Budget Act of 1997 aimed to reduce the federal deficit by curbing spending growth in the Medicare program. While it succeeded in its fiscal goals, it effectively signaled the beginning of the "underpayment era" for hospital systems.
- 2000s: The Era of Shifting Costs. Throughout the early 2000s, hospitals successfully navigated the gap by shifting the burden to commercial insurers. As commercial premiums climbed, providers used that revenue to cover the deficits incurred by Medicare and Medicaid patients.
- 2010–2020: The Rise of Employer Pushback. As healthcare costs began to consume a larger percentage of corporate budgets, employers—who fund the majority of commercial plans—began to demand transparency and cost-containment, making it increasingly difficult for hospitals to rely on commercial rates as a “blank check” to offset government losses.
- 2020–2026: The Post-Pandemic Pressure Cooker. The COVID-19 pandemic exacerbated staffing costs and supply chain expenses. With inflation surging and labor costs reaching historic highs, the thin margins that once buffered health systems against government underpayment have evaporated.
The Macroeconomic Drag: Why U.S. Competitiveness Suffers
Lee’s critique extends beyond the hospital walls, touching on the broader implications for the U.S. economy. He argues that the way the U.S. funds healthcare acts as a hidden tax on American manufacturing and innovation.
"U.S. products are becoming globally uncompetitive in part because healthcare costs are baked into their price," Lee explained. Because domestic companies are responsible for the lion’s share of health insurance premiums for their employees—costs that are inflated to cover the "hidden tax" of hospital underpayment—the final price of American-made goods rises. In a global marketplace, this makes U.S. goods more expensive than those produced in countries with socialized healthcare systems, where healthcare costs are decoupled from employment.
The Specter of a Two-Tiered System
The most alarming implication of this financial strain is the potential for prioritized access. If a hospital system is effectively losing 20% to 50% on every patient covered by government insurance, the economic incentive to prioritize those patients diminishes.
"If this continues, my guess is that we’re going to end up creating a two-tier system: one for commercial payers and those who can afford to pay out of pocket, and a different system for Medicare and Medicaid patients," Lee declared.
This scenario suggests that, in the near future, patients with private insurance may be funneled into "premium" lanes with shorter wait times and faster access to specialists, while Medicare and Medicaid patients may face systemic delays. While most hospitals currently operate under ethical mandates to treat all patients equally, the "breaking point" Lee describes suggests that financial survival may eventually supersede these ideals.
Institutional Fragility vs. Payer Mobility
A critical distinction in Lee’s argument is the difference between the "local" nature of healthcare providers and the "national" nature of health insurance payers.
Health systems like MultiCare are tethered to their communities. As Lee noted, MultiCare has been part of the Washington state landscape for 140 years. They cannot "exit" a market simply because the margins are slim. In contrast, national insurance carriers operate with much greater mobility. If a specific state’s regulatory environment or reimbursement landscape becomes unprofitable, a large insurer can choose to exit or reduce its footprint in that market within a single fiscal quarter.
"While these national payers can come to Washington and leave Washington, we can’t—Washington is our home," Lee said. This leaves the burden of systemic risk almost entirely on the providers, who lack the exit strategy available to their financial counterparts.
Official Responses and Industry Outlook
The healthcare industry is currently in a state of high anxiety regarding these projections. While organizations like the American Hospital Association (AHA) have long lobbied for higher Medicare and Medicaid reimbursement rates, the federal government has historically resisted, citing the need to manage the long-term solvency of the Medicare Trust Fund.
Industry analysts observe that the trend toward consolidation—where smaller, independent hospitals are absorbed into larger health systems—is largely a reaction to this fiscal pressure. By achieving scale, systems hope to gain the leverage necessary to negotiate better rates with private payers. However, regulators have begun to scrutinize this consolidation, fearing it leads to higher costs for consumers, creating a "catch-22" for hospitals.
Implications for the Future of Care
If the trends identified by Lee continue, the following implications for the U.S. healthcare landscape appear likely:
- Increased Wait Times for Government Beneficiaries: As systems struggle to remain solvent, administrative triage will likely prioritize patients who provide a positive margin, naturally pushing government-insured patients to the back of the queue.
- Specialization of Facilities: We may see a rise in "boutique" or "concierge" clinics that exclusively serve commercial or self-pay patients, further hollowing out the availability of primary care for the general population.
- Political Instability: The growing disparity between commercial and government coverage is likely to become a central political issue. As the middle class finds itself increasingly squeezed by high premiums and low access, the demand for radical healthcare reform will intensify.
- Operational Transformation: Health systems will be forced to aggressively pursue automation and AI-driven clinical efficiency. If they cannot increase revenue, they must drastically reduce the cost of care delivery to match the government’s reimbursement rates.
Conclusion: The Path Forward
James Lee’s testimony at the HFMA conference serves as a warning that the American healthcare system is currently living on borrowed time—and borrowed money. The model that worked in the late 20th century is failing to meet the demands of the 21st.
For the system to avoid the "separate and unequal" future that Lee fears, stakeholders must address the underlying economic imbalance. This requires a difficult conversation about the true cost of care, the role of government funding, and the sustainability of a system that relies on a shrinking pool of commercial patients to subsidize the health of the nation’s most vulnerable populations. As it stands, the "breaking point" is no longer a distant theoretical concern; for many health systems, it is the reality of their daily operations.
